Atlas Trials

A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy

Clinical trial NCT04151563 · WITHDRAWN

Trial details

NCT number
NCT04151563
Sponsor
Bristol-Myers Squibb
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-small Cell Lung Cancer
Start date
2021-04-15
Primary completion
2023-12-17
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.